CDMO Solutions
for Pharma & Biotech
Formulation Development, Drug Delivery and GMP Manufacturing
Supporting pharmaceutical innovators overcome challenges related to solubility, permeability, bioavailability, manufacturability and product performance.
From Formulation Development to Commercial Manufacturing
At TETRAPHARM, we provide integrated CDMO services that support pharmaceutical products through their lifecycle - from early-stage formulation development to GMP manufacturing and scale up.
A System-Based Approach to Drug Development
Drug development is rarely limited by the active pharmaceutical ingredient alone. The success of a pharmaceutical product depends on:
Molecule and formulation design
Drug delivery technology
Manufacturing process capability
Product quality and stability
At TETRAPHARM, we approach drug development from a systems perspective, ensuring that formulation, process development, analytical sciences and manufacturing considerations are aligned from the early stages of development.
This integration plays an important role in reducing development risk, shortening timelines and facilitating a smoother path to clinical development.
Addressing Complex Drug Development Challenges
Development risk often increases when drug characteristics, formulation design, drug delivery strategy and manufacturing considerations are not aligned early.
-
May limit dissolution and therapeutic performance.
-
May prevent efficient absorption even if the drug is soluble.
-
May reduce drug exposure and effectiveness.
-
Drug may be susceptible to degradation during processing or storage.
-
Products must remain robust, reproducible and scalable throughout development and commercialization.
Why TETRAPHARM?
-
Formulation, drug delivery, and manufacturing aligned from the beginning.
-
Access to ZYNDIKATE® drug-delivery technologies and formulation expertise.
-
Oral, sublingual, intranasal and transdermal options.
-
Designed with manufacturability, commercial scalability and lifecycle value in mind.
-
Reduced development risk
Shorter development timelines
Improved manufacturability
Smoother transition into clinical development
ZYNDIKATE® in short
One platform. Multiple possibilities.
ZYNDIKATE® combines formulation and delivery technologies to support highly lipophilic and poorly water-soluble small molecules.
Development Challenges that are address by ZYNDIKATE®
Poor Solubility
Your Challenge
Poor solubility limits therapeutic performance.
How ZYNDIKATE® May Help
Enhanced solubilization and improved drug uptake.
Limited Bioavailability
Your Challenge
Insufficient absorption reduces systemic exposure.
How ZYNDIKATE® May Help
Alternative delivery pathways and enhanced bioavailability.
Alternative Delivery Routes
Your Challenge
Conventional dosage forms do not meet patient needs.
How ZYNDIKATE® May Help
Flexible administration routes including oral, sublingual, intranasal and transdermal delivery.
Lifecycle Management
Your Challenge
Products require differentiation or lifecycle extension.
How ZYNDIKATE® May Help
Novel formulation and delivery strategies that create additional value.
Scalable Manufacturing
Your Challenge
Development programs require scalable manufacturing solutions.
How ZYNDIKATE® May Help
Supports scalable development from formulation to manufacturing.
Development Risk
Your Challenge
Complex development programs can increase risk and timelines.
How ZYNDIKATE® May Help
Aligns formulation, delivery and manufacturing from the start.
Ready to explore new development possibilities?
Whether you are advancing a novel therapeutic candidate or improving an existing product, our team can help identify a development pathway.
Henrik Lundorff
Chief Commercial Officer
Email
Multiple Delivery Strategies. One Integrated Platform.
From oral and sublingual delivery to intranasal and transdermal administration, ZYNDIKATE® supports a range of product development pathways.
Explore related areas of expertise and discover how our integrated approach supports pharmaceutical innovation.